• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

    7/17/24 6:03:31 AM ET
    $ADVM
    $APVO
    $ASML
    $ASST
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADVM alert in real time by email

    Shares of Bloom Energy Corporation (NYSE:BE) rose sharply in today's pre-market trading after the company announced a strategic partnership with CoreWeave.

    Bloom Energy said it entered into a partnership to deploy its proprietary fuel cells to generate on-site power for CoreWeave at a high-performance data center in Illinois.

    Bloom Energy shares jumped 12.1% to $16.90 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Shimmick Corporation (NASDAQ:SHIM) gained 53% to $3.09 in pre-market trading after the company received a $27.6 million subcontract for the Sunol Valley Water Treatment Plant Ozonation Project.
    • Aptevo Therapeutics Inc. (NASDAQ:APVO) shares rose 39.3% to $0.46 in pre-market trading after surging around 10% on Tuesday. Aptevo Therapeutics recently announced closing of $2.75 million offering.
    • MicroAlgo Inc. (NASDAQ:MLGO) shares rose 26.1% to $3.58 in pre-market trading after declining around 14% on Tuesday.
    • Conduit Pharmaceuticals Inc. (NASDAQ:CDT) rose 16.1% to $0.2916 in pre-market trading. Conduit Pharmaceuticals shares gained around 5% on Tuesday after the company announced it received patent approval for its lead asset targeting autoimmune diseases..
    • Adverum Biotechnologies, Inc. (NASDAQ:ADVM) shares gained 15.5% to $10.31 in pre-market trading. Adverum Biotechnologies revealed 26-week interim analysis results of Ixo-vec from LUNA Phase 2 trial at 2024 ASRS Annual Meeting.
    • GitLab Inc. (NASDAQ:GTLB) gained 13.9% to $57.71 in pre-market trading after Reuters reported that the company is exploring a sale.
    • Asset Entities Inc. (NASDAQ:ASST) shares climbed 12.6% to $1.77 in pre-market trading.
    • Immersion Corporation (NASDAQ:IMMR) shares surged 12.4% to $13.69 in pre-market trading after gaining over 5% on Tuesday.
    • CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) shares gained 7.7% to $0.21 in pre-market trading.

    Losers

    • Cineverse Corp (NASDAQ:CNVS) shares fell 15.6% to $0.75 in pre-market trading.
    • Logistic Properties of the Americas (NYSE:LPA) shares fell 15.2% to $22.04 in pre-market trading after jumping 69% on Tuesday.
    • Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) shares fell 15.2% to $1.28 in pre-market trading after jumping 41% on Tuesday.
    • Five Below, Inc. (NASDAQ:FIVE) shares declined 14.7% to $87.00 in pre-market trading after the company announced a CEO transition. Additionally, comparable sales decreased in the 10-week period ended July 13.
    • Safe and Green Development Corporation (NASDAQ:SGD) shares dipped 11% to $0.3642 in pre-market trading.
    • Silo Pharma, Inc. (NASDAQ:SILO) shares fell 9.2% to $2.17 in pre-market trading. Silo Pharma shares jumped 123% on Tuesday after the company obtained an exclusive global license to develop, manufacture, and commercialize its Alzheimer’s drug.
    • Eightco Holdings Inc. (NASDAQ:OCTO) shares fell 8.7% to $0.48 in pre-market trading. Eightco Holdings recently said first-quarter revenue fell to $9.6 million from $15.9 million in the year-ago period.
    • Cerus Corporation (NASDAQ:CERS) fell 8.4% to $2.19 in pre-market trading. On July 2, Cerus announced the appointment of Dean Gregory to its Board of Directors.
    • Siebert Financial Corp. (NASDAQ:SIEB) fell 6.8% to $1.77 in pre-market trading after gaining over 9% on Tuesday.
    • ASML Holding N.V.  (NASDAQ:ASML) shares declined 6.8% to $995.90 in pre-market trading. ASML reported better-than-expected second-quarter earnings, driven by robust sales in China and a surge in new bookings.

    Now Read This:

    • Jim Cramer Says If You Sell This Chinese EV Stock Now, ‘Some Clown’ Will Be ‘Real Positive About It,’ Wait Until ‘All That Stuff Happens’
    Get the next $ADVM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADVM
    $APVO
    $ASML
    $ASST

    CompanyDatePrice TargetRatingAnalyst
    Bloom Energy Corporation
    $BE
    12/2/2025Neutral
    Daiwa Securities
    GitLab Inc.
    $GTLB
    11/19/2025$44.00Buy → Hold
    Truist
    Adverum Biotechnologies Inc.
    $ADVM
    11/17/2025Buy → Neutral
    H.C. Wainwright
    ASML Holding N.V. New York Registry Shares
    $ASML
    11/7/2025Neutral → Buy
    Rothschild & Co Redburn
    Bloom Energy Corporation
    $BE
    10/29/2025$150.00Hold → Buy
    HSBC Securities
    Bloom Energy Corporation
    $BE
    10/29/2025$65.00 → $105.00Hold
    TD Cowen
    Five Below Inc.
    $FIVE
    10/27/2025$186.00Neutral → Overweight
    Analyst
    Bloom Energy Corporation
    $BE
    10/9/2025$100.00Buy → Hold
    HSBC Securities
    More analyst ratings

    $ADVM
    $APVO
    $ASML
    $ASST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Daiwa Securities initiated coverage on Bloom Energy

    Daiwa Securities initiated coverage of Bloom Energy with a rating of Neutral

    12/2/25 3:28:35 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    GitLab downgraded by Truist with a new price target

    Truist downgraded GitLab from Buy to Hold and set a new price target of $44.00

    11/19/25 8:54:30 AM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    Adverum Biotech downgraded by H.C. Wainwright

    H.C. Wainwright downgraded Adverum Biotech from Buy to Neutral

    11/17/25 9:39:07 AM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADVM
    $APVO
    $ASML
    $ASST
    SEC Filings

    View All

    Amendment: GitLab Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K/A - Gitlab Inc. (0001653482) (Filer)

    12/3/25 6:00:54 AM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    SEC Form 424B3 filed by CERo Therapeutics Holdings Inc.

    424B3 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Filer)

    12/2/25 5:18:18 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 424B3 filed by CERo Therapeutics Holdings Inc.

    424B3 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Filer)

    12/2/25 5:17:10 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADVM
    $APVO
    $ASML
    $ASST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Financial Officer Yoder Todd Wilbur bought $5,600 worth of shares (2,000 units at $2.80) (SEC Form 4)

    4/A - Shimmick Corp (0001887944) (Issuer)

    12/2/25 4:18:47 PM ET
    $SHIM
    Military/Government/Technical
    Industrials

    Chief Executive Officer Weisblum Eric bought $735 worth of shares (2,000 units at $0.37), increasing direct ownership by 0.95% to 211,932 units (SEC Form 4)

    4 - Silo Pharma, Inc. (0001514183) (Issuer)

    11/21/25 6:35:50 PM ET
    $SILO
    Apparel
    Consumer Discretionary

    Chief Executive Officer Weisblum Eric bought $4,847 worth of shares (12,000 units at $0.40), increasing direct ownership by 6% to 209,932 units (SEC Form 4)

    4 - Silo Pharma, Inc. (0001514183) (Issuer)

    11/20/25 4:00:32 PM ET
    $SILO
    Apparel
    Consumer Discretionary

    $ADVM
    $APVO
    $ASML
    $ASST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GitLab Appoints Jessica Ross As Chief Financial Officer

    All Remote, GitLab Inc. (NASDAQ:GTLB), the most comprehensive, intelligent DevSecOps platform, today announced the appointment of Jessica Ross as chief financial officer, effective January 15, 2026. Ross succeeds Interim CFO James Shen, who will return to his role as vice president of finance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251202385769/en/Jessica Ross Ross' appointment comes as GitLab continues to see strong momentum, achieving 25% revenue growth in the third quarter of fiscal year 2026. She will oversee GitLab's global finance, accounting, and investor relations functions as the company accelerates DevSecOps inn

    12/2/25 4:06:00 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    GitLab Reports Third Quarter Fiscal Year 2026 Financial Results

    Third Quarter Fiscal Year 2026 Highlights: Total revenue of $244.4 million, up 25% year-over-year GAAP operating margin of (5)%; non-GAAP operating margin of 18% Operating cash flow of $31.4 million and non-GAAP adjusted free cash flow of $27.2 million All-Remote - GitLab Inc. (NASDAQ:GTLB), the most comprehensive, intelligent DevSecOps platform, today reported financial results for its third quarter fiscal year of 2026, ended October 31, 2025. "More code means more of a need for GitLab," said Bill Staples, GitLab chief executive officer. "Engagement is growing across our platform as we are a critical part of how our customers deliver high quality, secure software. We've architecte

    12/2/25 4:05:00 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    CERo Therapeutics Announces Trading on OTCQB Market

    Company's Shares Will Continue to Trade Under Ticker CERO SOUTH SAN FRANCISCO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (OTCQB: CERO) ("CERo" or the "Company"), an innovative cellular immunotherapy company developing novel T cell therapeutics that incorporate phagocytic mechanisms, announces its shares will be available to trade on the OTCQB market under the ticker symbol CERO effective today, December 2, 2025 as of 8:00AM ET.  No action is needed on the part of investors. In the meantime, CERo continues to evaluate additional options for up-list, including, but not limited to listing on a major exchange to optimize liquidity and investor accessibility.

    12/2/25 7:30:00 AM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADVM
    $APVO
    $ASML
    $ASST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Financial Officer Yoder Todd Wilbur bought $5,600 worth of shares (2,000 units at $2.80) (SEC Form 4)

    4/A - Shimmick Corp (0001887944) (Issuer)

    12/2/25 4:18:47 PM ET
    $SHIM
    Military/Government/Technical
    Industrials

    Chief Commercial Officer Joshi Aman sold $1,467,000 worth of shares (15,000 units at $97.80), decreasing direct ownership by 7% to 204,818 units (SEC Form 4)

    4 - Bloom Energy Corp (0001664703) (Issuer)

    12/1/25 4:14:50 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    New insider Solimene Lewis claimed no ownership of stock in the company (SEC Form 3)

    3 - SIEBERT FINANCIAL CORP (0000065596) (Issuer)

    11/28/25 3:00:09 PM ET
    $SIEB
    Investment Bankers/Brokers/Service
    Finance

    $ADVM
    $APVO
    $ASML
    $ASST
    Financials

    Live finance-specific insights

    View All

    GitLab Reports Third Quarter Fiscal Year 2026 Financial Results

    Third Quarter Fiscal Year 2026 Highlights: Total revenue of $244.4 million, up 25% year-over-year GAAP operating margin of (5)%; non-GAAP operating margin of 18% Operating cash flow of $31.4 million and non-GAAP adjusted free cash flow of $27.2 million All-Remote - GitLab Inc. (NASDAQ:GTLB), the most comprehensive, intelligent DevSecOps platform, today reported financial results for its third quarter fiscal year of 2026, ended October 31, 2025. "More code means more of a need for GitLab," said Bill Staples, GitLab chief executive officer. "Engagement is growing across our platform as we are a critical part of how our customers deliver high quality, secure software. We've architecte

    12/2/25 4:05:00 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    Five Below, Inc. Announces Third Quarter 2025 Earnings Release and Conference Call Date

    PHILADELPHIA, PA, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ:FIVE), the trend-right, extreme-value brand for kids, today announced that its financial results for the third quarter of fiscal 2025 will be released after market close on Wednesday, December 3, 2025. The company will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results. A live audio webcast of the conference call will be available online at investor.fivebelow.com, where a replay will be available shortly after conclusion of the call. Investors and analysts interested in participating in the call are invited to dial 412-902-6753 approximately 10 minutes prior to the start of the call

    11/19/25 4:01:00 PM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    GitLab To Announce Third Quarter Fiscal 2026 Financial Results

    All Remote - GitLab Inc., (NASDAQ:GTLB), the most comprehensive, intelligent DevSecOps platform, today announced that it will report its financial results for the third quarter of fiscal year 2026, which ended October 31, 2025, after U.S. markets close on Tuesday, December 2, 2025. Management will host a conference call and webcast on the same day to discuss the company's financial results at 4:30 p.m. ET / 1:30 p.m. PT. GitLab Third Quarter Fiscal 2026 Financial Results Conference Call and Webcast When: Tuesday, December 2, 2025 Time: 4:30 p.m. ET / 1:30 p.m. PT Earnings Call Registration Replay: A webcast replay of the conference call will be available on the investor relations

    11/18/25 4:05:00 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    $ADVM
    $APVO
    $ASML
    $ASST
    Leadership Updates

    Live Leadership Updates

    View All

    GitLab Appoints Jessica Ross As Chief Financial Officer

    All Remote, GitLab Inc. (NASDAQ:GTLB), the most comprehensive, intelligent DevSecOps platform, today announced the appointment of Jessica Ross as chief financial officer, effective January 15, 2026. Ross succeeds Interim CFO James Shen, who will return to his role as vice president of finance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251202385769/en/Jessica Ross Ross' appointment comes as GitLab continues to see strong momentum, achieving 25% revenue growth in the third quarter of fiscal year 2026. She will oversee GitLab's global finance, accounting, and investor relations functions as the company accelerates DevSecOps inn

    12/2/25 4:06:00 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    Lilly to Acquire Adverum Biotechnologies

    Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose  Acquisition aligns Lilly's genetic medicine capabilities with opportunity to expand gene therapy's potential to alleviate the burden of age-related diseases  INDIANAPOLIS and REDWOOD CITY, Calif., Oct. 24, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage company pioneering the use of intravitreal gene therapy with the aim of preserving sight for life in highly prevalent ocular diseases, today announced a definitive agreement for Lilly to acquire Adve

    10/24/25 8:30:00 AM ET
    $ADVM
    $LLY
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    ASML appoints next Chief Technology Officer

    ASML appoints next Chief Technology Officer Marco Pieters appointed ASML Chief Technology Officer ASML Supervisory Board intends to reappoint CFO Roger Dassen and COO Frédéric Schneider-Maunoury, and to appoint CTO Marco Pieters to the Board of Management as of the April 2026 AGM VELDHOVEN, The Netherlands, October 9, 2025 – ASML Holding NV (ASML) today announced the appointment of Marco Pieters as Executive Vice President and Chief Technology Officer, reporting to President and Chief Executive Officer, Christophe Fouquet. With over 25 years of experience at ASML, most recently as Executive Vice President for the product area Applications, Pieters has a strong track record in technology l

    10/9/25 2:00:00 AM ET
    $ASML
    Industrial Machinery/Components
    Technology

    $ADVM
    $APVO
    $ASML
    $ASST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CERo Therapeutics Holdings Inc.

    SC 13G - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    12/13/24 7:18:17 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by CERo Therapeutics Holdings Inc.

    SC 13G/A - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    11/20/24 4:06:55 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by CERo Therapeutics Holdings Inc.

    SC 13G - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    11/20/24 4:01:41 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care